TESOS – An Exciting NEW Fat-Loss Product!
Pharmacom Labs is launching a NEW Tesofensine product and Basicstero is looking for people to give it a try & share their experience.
Pharmacom Labs plans to offer this innovative Oral-Line Fat-Loss product as 0.5 mg tablets
*(Please see note at the end of this post) sealed in 50 count blister strips (similar to other Pharmacom Labs Oral-Line products).
Selected volunteers will receive a
FREE sample consisting of two fifty-count blister strips (for a total of 100 tablets) of the NEW
Pharmacom Tesofensine product in exchange for volunteers reviewing the product and posting about their experience while using this new product.
Basicstero would like multiple tester volunteers; thereofore, If interested and
willing to try the product and share the results of your experience please reply to this thread for consideration.
Feel free to reply even if others have already replied; many testers are wanted (it will be posted/updated if/when the source is no longer seeking volunteers).
Please reply to this thread if you are interested so Basicstero may select volunteers to receive and try a Free sample of this new product.
Tesofensine Information:
Tesofensine is a unique new generation Triple Serotonin Norepinephrine Dopamine Reuptake Inhibitor (SNDRI).
SNDRI belong to the class of psychoactive antidepressants. They affect neurotransmitters in the brain, exactly serotonin, norepinephrine and dopamine. Tesofensin affects the brain qualitatively, helping a person to feel maximum saturation during eating, and reduce appetite significantly.
Tesofensin was originally developed and patented by NeuroSearch A/S (Denmark) to cure Parkinson's and Alzheimer's diseases.
• acts centrally, suppress appetite, regulate the availability of dopamine receptors and stimulate α1-adrenergic receptors.
• appetite decreases within 14 days, there is a higher level of satiety and less desire to eat.
• increases significantly fat oxidation and reduces adipose tissue.
• improves the level of insulin sensitivity, which leads to higher glucose metabolism.
• alters the expression of dopaminergic receptors in the striatum of the brain, as well as their binding.
• the energy consumption increases greatly within 14 days.
• The drug has a long half-life, which is 8-9 days, and metabolized mainly in the liver by CYP3A4 to the disalkyl metabolite M1 (NS-2360), which is the only metabolite found in human blood plasma.
Chemical name: (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
Formula: C17H23Cl2NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
ACTIVE HALF-LIFE: 9 days
CLASSIFICATION: psychoactive antidepressants.
DOSAGE: 0.25 mg -1 mg
ACNE: no
WATER RETENTION: no
HBR: Perhaps
HEPATOXITY: Low
AROMATIZATION: no
*IMPORTANT NOTE: There is a typographical error on the blisters of these first batches that says 50mg instead of 0.5 mg; This is a mistake. The Pharmacom Labs Tesofensin product is produced as
0.5 mg tablets.
The Basicstero Team hopes you will enjoy this NEW Pharmacom Labs Fat-Loss product
and, we wish you all the best!
